MA49506B1 - Synthèse d'omecamtiv mecarbil - Google Patents

Synthèse d'omecamtiv mecarbil

Info

Publication number
MA49506B1
MA49506B1 MA49506A MA49506A MA49506B1 MA 49506 B1 MA49506 B1 MA 49506B1 MA 49506 A MA49506 A MA 49506A MA 49506 A MA49506 A MA 49506A MA 49506 B1 MA49506 B1 MA 49506B1
Authority
MA
Morocco
Prior art keywords
synthesis
omecamtiv mecarbil
omecamtiv
mecarbil
relates
Prior art date
Application number
MA49506A
Other languages
English (en)
Inventor
Sebastien Caille
Fang Wang
Xianqing Shi
Kyle Quasdorf
Philipp Roosen
Andrew Cosbie
Zufan Wu
Archana Neergunda
Bin Quan
Lianxiu Guan
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority claimed from PCT/US2018/040176 external-priority patent/WO2019006231A1/fr
Publication of MA49506B1 publication Critical patent/MA49506B1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne une synthèse pour l'hydrate de dichlorhydrate d'omecamtiv mecarbil et divers intermédiaires. (i)
MA49506A 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil MA49506B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762527174P 2017-06-30 2017-06-30
PCT/US2018/040176 WO2019006231A1 (fr) 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil

Publications (1)

Publication Number Publication Date
MA49506B1 true MA49506B1 (fr) 2021-09-30

Family

ID=68382486

Family Applications (1)

Application Number Title Priority Date Filing Date
MA49506A MA49506B1 (fr) 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil

Country Status (2)

Country Link
AR (1) AR112220A1 (fr)
MA (1) MA49506B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202300479A (zh) * 2021-03-10 2023-01-01 美商安進公司 奧美卡替莫卡必爾之合成

Also Published As

Publication number Publication date
AR112220A1 (es) 2019-10-02

Similar Documents

Publication Publication Date Title
EP3833739A4 (fr) Souche d'akkermansia muciniphila
ZA202000534B (en) Synthesis of omecamtiv mecarbil
MY203303A (en) Compounds
SG11201909186YA (en) Triazole silane compound, method for synthesizing said compound and use thereof
EA201892430A1 (ru) Синтез индазолов
EP3756664A4 (fr) Inhibiteur de différenciation d'ostéoclastes contenant de l'urolithine
UA122882C2 (uk) Синтез індазолів
MY188420A (en) Crystalline forms of (s)-afoxolaner
MA42776B1 (fr) Composés utiles pour l'inhibition du ror-gamma-t
PH12018500282A1 (en) Cgrp receptor antagonists
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
EP3939588A4 (fr) Utilisations d'inhibiteurs de la phosphodiestérase
EP3928298A4 (fr) Module de verrouillage de l'internet des objets
IL291221A (en) Methods for the synthesis of wolbenzine
ZA202004466B (en) Processes for the synthesis of sulfentrazone
MX2021000334A (es) Nuevas formas polimorficas de ciclo (-his-pro).
MA39126A3 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci
MX2019008375A (es) Tiobenzoimidazol como fungicidas.
MA41311B1 (fr) Peptides antagonistes du cgrp
EP3697415A4 (fr) Polythérapie pour la prévention d'une addiction
EP3608331A4 (fr) Peptide pour l'inhibition de biofilms
EP3911656A4 (fr) Synthèse de 14-méthyl-16-oxabicyclo [10.3.1] hexadéc-12-ène
EP3965749A4 (fr) Inhibition de l'usp19
EP3915346C0 (fr) Boîtier de l'émetteur
EP4001398A4 (fr) Lignée de champignon trichoderma modifiée pour la production d'un cocktail enzymatique